Pharma's Almanac

2870 Articles Available

1 120

FDA Statement

Statement from FDA Commissioner Scott Gottlieb, M.D., On New Policy to Improve Access for Drugs that Face Inadequate Generic Competition

PR-M02-19-NI-039

FDA

FDA Advances New Efforts to Promote Development of Safe and Effective Regenerative Medicine Products

PR-M02-19-NI-037

Oncology

Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi® (larotrectinib) and BAY 2731954 (LOXO-195)

PR-M02-19-NI-040

Clinical Trials

Avapritinib Receives Phase III Clinical Trial Approval for GIST in China

PR-M02-19-NI-038

Acquisition

Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.

PR-M02-19-NI-036

FDA Statement

Statement from FDA Commissioner Scott Gottlieb, M.D. on New Programs to Promote the Adoption of Innovations in Drug Manufacturing

PR-M02-19-NI-034

Collaboration

Abilita Bio and Amgen Enter Into a Multi-Target Collaboration

PR-M02-19-NI-035

Expansion

Discovery Life Sciences Launches Major European Expansion

PR-M02-19-NI-033

Research

Researchers May Have Found Method for Detecting Consciousness

PAO-M02-19-NI-012

Artificial Intelligence

Trump Signs Executive Order Launching the American AI Initiative

PAO-M02-19-NI-012

Research

Putting Mosquitoes on a Diet

PAO-M02-19-NI-011

FDA Statement

Statement from FDA Commissioner Scott Gottlieb, M.D., on Ongoing Efforts to Secure the U.S. Supply Chain and Confront the Opioid Epidemic

PR-M02-19-NI-032

Immunotherapy

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy

PR-M02-19-NI-031

FDA

FDA Advisory Committee Recommends Approval of SPRAVATO™ (esketamine) Nasal Spray CIII for Adults with Treatment-Resistant Depression

PR-M02-19-NI-030

Oncology

Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare's SRT-100™ for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities

PR-M02-19-NI-029

Genetic Testing

Invitae Launches Non-Invasive Prenatal Screening (NIPS), Offering In-Depth Genetic Information in Early Pregnancy

PR-M02-19-NI-031

License Agreement

Applied Biology to Enter into a License Agreement with Hairmore for its Novel Treatment for Traction Alopecia

PR-M02-19-NI-030

Funding

Culture Biosciences Secures $5.5M to Pioneer Biomanufacturing-as-a-Service

PR-M02-19-NI-029

FDA Approval

U.S. FDA Approves DARZALEX® (daratumumab) Split-Dosing Regimen

PR-M02-19-NI-028

Oral Insulin

An Innovative Approach to Oral Insulin

PAO-M02-19-NI-010

Drug Pricing

Price Lowered on Cholesterol Drugs

PAO-M02-19-NI-009

Supplements

Statement from FDA on the Agency's Efforts to Strengthen Regulation of Dietary Supplements

PR-M02-19-NI-026

FDA

BioArctic: U.S. Food and Drug Administration Approves Investigational New Drug Applicationfor ABBV-0805

PR-M02-19-NI-025

Funding

Human API Announces New Investors, $10M in Funding, to Grow Consumer Health Data Network

PR-M02-19-NI-027

1 120

»